How can the latest technologies advance cell therapy manufacturing?

Area of Science:

• Cellular Therapy
• Immunotherapy
• Biotechnology

Background:

• Cellular therapies demonstrate initial safety and efficacy but face significant translation challenges.
• Technical and regulatory obstacles hinder rapid progress, especially for widespread clinical use and multicenter trials.
• Deficits in cGMP-compliant manufacturing and integrated processes necessitate innovative solutions.

Purpose of the Study:

• To review recent technological developments overcoming manufacturing challenges in cellular therapies.
• To highlight advancements in T-cell therapies, focusing on regulatory T cells for transplantation and autoimmunity.
• To discuss the integration of multistep procedures and automation in clinical cell processing.

Main Methods:

• Review of recent developments in clinical cell sorting and T-cell subset identification.
• Analysis of advancements in in-vitro cell culture technologies and automation.
• Focus on integration of multistep procedures for clinical manufacturing.

Main Results:

• New technologies in cell sorting, T-cell identification, and in-vitro culture offer solutions for clinical cell processing.
• Automation and simplified, integrated manufacturing processes are emerging.
• These developments are crucial for overcoming long-standing issues in the field.

Conclusions:

• Technological progress in simplification, integration, and automation is vital for successful cellular therapies.
• These advancements are key to the broad implementation of cellular therapies in clinical settings.
• Overcoming manufacturing challenges will accelerate the development and application of T-cell-based therapies.